Anti-MAP Triple Therapy Supports Immunomodulatory Therapeutic Response in Crohn’s Disease through Downregulation of NF-κB Activation in the Absence of MAP Detection

We previously reported that the triple antibiotic formulation, known as anti-MAP therapy, exhibits unique synergistic antimicrobial activity and should be effective for treatment of Crohn’s disease (CD) associated with Mycobacterium avium subspecies paratuberculosis (MAP). The absence of MAP detecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Qasem, Ahmad, Elkamel, Erij, Naser, Saleh A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698721/
https://www.ncbi.nlm.nih.gov/pubmed/33217961
http://dx.doi.org/10.3390/biomedicines8110513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698721/
https://www.ncbi.nlm.nih.gov/pubmed/33217961
http://dx.doi.org/10.3390/biomedicines8110513

Ejemplares similares